Bhatia, Shailender
Pavlick, Anna C.
Boasberg, Peter
Thompson, John A.
Mulligan, George
Pickard, Michael D.
Faessel, Hélène
Dezube, Bruce J.
Hamid, Omid
Article History
Received: 17 February 2016
Accepted: 18 March 2016
First Online: 8 April 2016
Compliance with ethical standards
:
: SB: Nothing to disclose. ACP: Nothing to disclose. JAT: Nothing to disclose. PB: Nothing to disclose. GM, MDP, HF, BJD: employment, Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited. OH: Nothing to disclose.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Written informed consent was obtained from all individual participants included in the study.
: This study was funded by Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited.
: Employees of Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, participated in trial design, data collection, data analysis, data interpretation, and writing of the report. The Sponsor of the study was involved in the design of the trial and provided grants to trial sites and had no other involvement in conduct of trial. The Sponsor also provided funding for writing support during the development of this manuscript. The corresponding author had full access to all the data in the study and had final responsibility for the decision to submit for publication.